TreeWAS – Variant ID: rs17074636

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I35.0 Aortic (valve) stenosis	0.008	0.992	0.000
R55 Syncope and collapse	0.000	0.992	0.008
I35.1 Aortic (valve) insufficiency	0.007	0.993	0.000
R69 Unknown and unspecified causes of morbidity	0.000	0.993	0.007
I35 Nonrheumatic aortic valve disorders	0.007	0.993	0.000
R50-R69 General symptoms and signs	0.000	0.994	0.006
R61 Hyperhidrosis	0.000	0.994	0.006
R63 Symptoms and signs concerning food and fluid intake	0.000	0.994	0.005
R61.9 Hyperhidrosis, unspecified	0.000	0.995	0.005
R52 Pain, not elsewhere classified	0.000	0.995	0.005
R63.4 Abnormal weight loss	0.000	0.995	0.005
R59 Enlarged lymph nodes	0.000	0.995	0.005
R52.1 Chronic intractable pain	0.000	0.995	0.005
I35.9 Aortic valve disorder, unspecified	0.005	0.995	0.000
I35.8 Other aortic valve disorders	0.005	0.995	0.000
I35.2 Aortic (valve) stenosis with insufficiency	0.005	0.995	0.000
R54 Senility	0.000	0.995	0.005
R60 Oedema, not elsewhere classified	0.000	0.995	0.005
R65 Systemic Inflammatory Response Syndrome [SIRS]	0.000	0.995	0.005
R62 Lack of expected normal physiological development	0.000	0.995	0.005
R57 Shock, not elsewhere classified	0.000	0.995	0.005
R64 Cachexia	0.000	0.995	0.005
R58 Haemorrhage, not elsewhere classified	0.000	0.995	0.005
R68 Other general symptoms and signs	0.000	0.995	0.004
R52.2 Other chronic pain	0.000	0.996	0.004
R59.1 Generalised enlarged lymph nodes	0.000	0.996	0.004
R61.1 Generalised hyperhidrosis	0.000	0.996	0.004
R61.0 Localised hyperhidrosis	0.000	0.996	0.004
R50 Fever of unknown origin	0.000	0.996	0.004
R63.6 Insufficient intake of food and water due to self neglect	0.000	0.996	0.004
R63.5 Abnormal weight gain	0.000	0.996	0.004
R63.3 Feeding difficulties and mismanagement	0.000	0.996	0.004
R63.2 Polyphagia	0.000	0.996	0.004
R63.1 Polydipsia	0.000	0.996	0.004
R52.0 Acute pain	0.000	0.996	0.004
G31.9 Degenerative disease of nervous system, unspecified	0.004	0.996	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.996	0.004
R56 Convulsions, not elsewhere classified	0.000	0.996	0.004
C44.1 Skin of eyelid, including canthus	0.004	0.996	0.000
R59.0 Localised enlarged lymph nodes	0.000	0.996	0.004
R60.9 Oedema, unspecified	0.000	0.996	0.004
R59.9 Enlarged lymph nodes, unspecified	0.000	0.996	0.004
R60.1 Generalised oedema	0.000	0.996	0.004
R63.0 Anorexia	0.000	0.996	0.004
R57.9 Shock, unspecified	0.000	0.996	0.003
R57.8 Other shock	0.000	0.996	0.003
R57.2 Septic shock	0.000	0.996	0.003
R57.1 Hypovolaemic shock	0.000	0.996	0.003
R57.0 Cardiogenic shock	0.000	0.996	0.003
R62.9 Lack of expected normal physiological development, unspecified	0.000	0.996	0.003
R62.8 Other lack of expected normal physiological development	0.000	0.996	0.003
R62.0 Delayed milestone	0.000	0.996	0.003
R65.9 Systemic Inflammatory Response Syndrome, unspecified	0.000	0.996	0.003
R65.3 Systemic Inflammatory Response Syndrome of non-infectious origin with organ failure	0.000	0.996	0.003
R65.2 Systemic Inflammatory Response Syndrome of non-infectious origin without organ failure	0.000	0.996	0.003
R65.1 Systemic Inflammatory Response Syndrome of infectious origin with organ failure	0.000	0.996	0.003
R65.0 Systemic Inflammatory Response Syndrome of infectious origin without organ failure	0.000	0.996	0.003
R68.3 Clubbing of fingers	0.000	0.996	0.003
R68.2 Dry mouth, unspecified	0.000	0.996	0.003
R68.1 Nonspecific symptoms peculiar to infancy	0.000	0.996	0.003
R68.0 Hypothermia, not associated with low environmental temperature	0.000	0.996	0.003
R60.0 Localised oedema	0.000	0.996	0.003
I84.2 Internal haemorrhoids without complication	0.000	0.996	0.004
R52.9 Pain, unspecified	0.000	0.996	0.003
R68.8 Other specified general symptoms and signs	0.000	0.997	0.003
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.997	0.003
R50.8 Other specified fever	0.000	0.997	0.003
R50.2 Drug-induced fever	0.000	0.997	0.003
R50.1 Persistent fever	0.000	0.997	0.003
R50.0 Fever with chills	0.000	0.997	0.003
C44 Other malignant neoplasms of skin	0.003	0.997	0.000
C44.6 Skin of upper limb, including shoulder	0.003	0.997	0.000
R56.0 Febrile convulsions	0.000	0.997	0.003
Y83.6 Removal of other organ (partial) (total)	0.000	0.997	0.003
R51 Headache	0.000	0.997	0.003
C44.4 Skin of scalp and neck	0.003	0.997	0.000
C79 Secondary malignant neoplasm of other sites	0.003	0.997	0.000
C34.1 Upper lobe, bronchus or lung	0.003	0.997	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.003	0.997	0.000
R50.9 Fever, unspecified	0.000	0.997	0.003
C44.7 Skin of lower limb, including hip	0.003	0.997	0.000
C44.5 Skin of trunk	0.003	0.997	0.000
R53 Malaise and fatigue	0.000	0.997	0.003
C79.6 Secondary malignant neoplasm of ovary	0.003	0.997	0.000
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.997	0.003
C44.9 Malignant neoplasm of skin, unspecified	0.003	0.997	0.000
C44.8 Overlapping lesion of skin	0.003	0.997	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.003	0.997	0.000
C44.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
C44.0 Skin of lip	0.003	0.997	0.000
R56.8 Other and unspecified convulsions	0.000	0.997	0.002
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.002	0.997	0.000
C34 Malignant neoplasm of bronchus and lung	0.002	0.997	0.000
C34.9 Bronchus or lung, unspecified	0.002	0.997	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.002	0.998	0.000
C79.2 Secondary malignant neoplasm of skin	0.002	0.998	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.002	0.998	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.002	0.998	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.002	0.998	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.002	0.998	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.002	0.998	0.000
W19.4 Street and highway	0.002	0.998	0.000
M19.91 Arthrosis, unspecified (Shoulder region)	0.002	0.998	0.000
W19.2 School, other institution and public administrative area	0.002	0.998	0.000
W19 Unspecified fall	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.002	0.998	0.000
W19.9 Unspecified place	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
G31.2 Degeneration of nervous system due to alcohol	0.002	0.998	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.002	0.998	0.000
G31.0 Circumscribed brain atrophy	0.002	0.998	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.002	0.998	0.000
C34.8 Overlapping lesion of bronchus and lung	0.002	0.998	0.000
C34.2 Middle lobe, bronchus or lung	0.002	0.998	0.000
C34.0 Main bronchus	0.002	0.998	0.000
Y83.8 Other surgical procedures	0.000	0.998	0.002
M16.1 Other primary coxarthrosis	0.002	0.998	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.002	0.998	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.002	0.998	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.002	0.998	0.000
G47.3 Sleep apnoea	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D37.1 Stomach	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.998	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
D37.5 Rectum	0.002	0.998	0.000
W19.8 Other specified place	0.002	0.998	0.000
W19.5 Trade and service area	0.002	0.998	0.000
W19.0 Home	0.002	0.998	0.000
W19.7 Farm	0.002	0.998	0.000
W19.6 Industrial and construction area	0.002	0.998	0.000
W19.3 Sports and athletics area	0.002	0.998	0.000
W19.1 Residential institution	0.002	0.998	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.002	0.998	0.000
C44.2 Skin of ear and external auricular canal	0.001	0.998	0.000
C80 Malignant neoplasm without specification of site	0.002	0.998	0.000
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters	0.000	0.998	0.002
D41.4 Bladder	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
Y83.4 Other reconstructive surgery	0.000	0.998	0.002
C92 Myeloid leukaemia	0.002	0.998	0.000
C80.9 Malignant neoplasm, unspecified	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.002	0.998	0.000
Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.998	0.002
D37.9 Digestive organ, unspecified	0.002	0.998	0.000
D37.7 Other digestive organs	0.002	0.998	0.000
D37.6 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D37.4 Colon	0.002	0.998	0.000
D37.3 Appendix	0.002	0.998	0.000
D37.2 Small intestine	0.002	0.998	0.000
D37.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.002	0.998	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.002	0.998	0.000
C31 Malignant neoplasm of accessory sinuses	0.002	0.998	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.002	0.998	0.000
C37 Malignant neoplasm of thymus	0.002	0.998	0.000
C33 Malignant neoplasm of trachea	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.002	0.998	0.000
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
D47.2 Monoclonal gammopathy	0.002	0.998	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.002	0.998	0.000
D46 Myelodysplastic syndromes	0.002	0.998	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.002	0.998	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.002	0.998	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.002	0.998	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.002	0.998	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.002	0.998	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.002	0.998	0.000
C34.3 Lower lobe, bronchus or lung	0.001	0.998	0.000
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.001	0.998	0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.001	0.998	0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.001	0.998	0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.001	0.998	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.998	0.002
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.002	0.998	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.002	0.998	0.000
Chapter II Neoplasms	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.001	0.998	0.000
D41.9 Urinary organ, unspecified	0.001	0.998	0.000
D41.7 Other urinary organs	0.001	0.998	0.000
D41.3 Urethra	0.001	0.998	0.000
D41.2 Ureter	0.001	0.998	0.000
D41.1 Renal pelvis	0.001	0.998	0.000
D41.0 Kidney	0.001	0.998	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.000	0.998	0.002
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.001	0.998	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.002	0.998	0.000
G47 Sleep disorders	0.000	0.998	0.002
S42.40 Fracture of lower end of humerus (closed)	0.001	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.001	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.998	0.000
C92.7 Other myeloid leukaemia	0.001	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.001	0.998	0.000
C92.3 Myeloid sarcoma	0.001	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.001	0.998	0.000
C90.0 Multiple myeloma	0.001	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.998	0.000
C91.7 Other lymphoid leukaemia	0.001	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.998	0.000
C91.5 Adult T-cell leukaemia	0.001	0.998	0.000
C91.4 Hairy-cell leukaemia	0.001	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.001	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.001	0.998	0.000
C91.0 Acute lymphoblastic leukaemia	0.001	0.998	0.000
Y83.5 Amputation of limb(s)	0.000	0.998	0.001
Y83.3 Surgical operation with formation of external stoma	0.000	0.998	0.001
Y83.0 Surgical operation with transplant of whole organ	0.000	0.998	0.001
Z51.5 Palliative care	0.002	0.998	0.000
D45 Polycythaemia vera	0.001	0.998	0.000
C30.1 Middle ear	0.001	0.998	0.000
C30.0 Nasal cavity	0.001	0.998	0.000
C31.9 Accessory sinus, unspecified	0.001	0.998	0.000
C31.8 Overlapping lesion of accessory sinuses	0.001	0.998	0.000
C31.3 Sphenoidal sinus	0.001	0.998	0.000
C31.2 Frontal sinus	0.001	0.998	0.000
C31.1 Ethmoidal sinus	0.001	0.998	0.000
C31.0 Maxillary sinus	0.001	0.998	0.000
C32.9 Larynx, unspecified	0.001	0.998	0.000
C32.8 Overlapping lesion of larynx	0.001	0.998	0.000
C32.3 Laryngeal cartilage	0.001	0.998	0.000
C32.2 Subglottis	0.001	0.998	0.000
C32.1 Supraglottis	0.001	0.998	0.000
C32.0 Glottis	0.001	0.998	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.001	0.998	0.000
C38.4 Pleura	0.001	0.998	0.000
C38.3 Mediastinum, part unspecified	0.001	0.998	0.000
C38.2 Posterior mediastinum	0.001	0.998	0.000
C38.1 Anterior mediastinum	0.001	0.998	0.000
C38.0 Heart	0.001	0.998	0.000
C39.9 Ill-defined sites within the respiratory system	0.001	0.998	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.001	0.998	0.000
C39.0 Upper respiratory tract, part unspecified	0.001	0.998	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.001	0.998	0.000
C76.7 Other ill-defined sites	0.001	0.998	0.000
C76.5 Lower limb	0.001	0.998	0.000
C76.4 Upper limb	0.001	0.998	0.000
C76.3 Pelvis	0.001	0.998	0.000
C76.2 Abdomen	0.001	0.998	0.000
C76.1 Thorax	0.001	0.998	0.000
C76.0 Head, face and neck	0.001	0.998	0.000
G47.9 Sleep disorder, unspecified	0.000	0.998	0.001
R07.3 Other chest pain	0.000	0.998	0.002
C90.3 Solitary plasmacytoma	0.001	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.001	0.998	0.000
C90.1 Plasma cell leukaemia	0.001	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.001	0.998	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.001	0.998	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.001	0.998	0.000
D46.4 Refractory anaemia, unspecified	0.001	0.998	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.001	0.998	0.000
D46.2 Refractory anaemia with excess of blasts	0.001	0.998	0.000
D46.1 Refractory anaemia with sideroblasts	0.001	0.998	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.001	0.998	0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.001	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.001	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.001	0.998	0.000
C83.7 Burkitt's tumour	0.001	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.001	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.001	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.001	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.001	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.001	0.998	0.000
D38.6 Respiratory organ, unspecified	0.001	0.998	0.000
D38.5 Other respiratory organs	0.001	0.998	0.000
D38.4 Thymus	0.001	0.998	0.000
D38.3 Mediastinum	0.001	0.998	0.000
D38.2 Pleura	0.001	0.998	0.000
D38.1 Trachea, bronchus and lung	0.001	0.998	0.000
D38.0 Larynx	0.001	0.998	0.000
D39.9 Female genital organ, unspecified	0.001	0.998	0.000
D39.7 Other female genital organs	0.001	0.998	0.000
D39.2 Placenta	0.001	0.998	0.000
D39.1 Ovary	0.001	0.998	0.000
D39.0 Uterus	0.001	0.998	0.000
D40.9 Male genital organ, unspecified	0.001	0.998	0.000
D40.7 Other male genital organs	0.001	0.998	0.000
D40.1 Testis	0.001	0.998	0.000
D40.0 Prostate	0.001	0.998	0.000
D42.9 Meninges, unspecified	0.001	0.998	0.000
D42.1 Spinal meninges	0.001	0.998	0.000
D42.0 Cerebral meninges	0.001	0.998	0.000
D43.9 Central nervous system, unspecified	0.001	0.998	0.000
D43.7 Other parts of central nervous system	0.001	0.998	0.000
D43.4 Spinal cord	0.001	0.998	0.000
D43.3 Cranial nerves	0.001	0.998	0.000
D43.2 Brain, unspecified	0.001	0.998	0.000
D43.1 Brain, infratentorial	0.001	0.998	0.000
D43.0 Brain, supratentorial	0.001	0.998	0.000
D44.9 Endocrine gland, unspecified	0.001	0.998	0.000
D44.8 Pluriglandular involvement	0.001	0.998	0.000
D44.7 Aortic body and other paraganglia	0.001	0.998	0.000
D44.6 Carotid body	0.001	0.998	0.000
D44.5 Pineal gland	0.001	0.998	0.000
D44.4 Craniopharyngeal duct	0.001	0.998	0.000
D44.3 Pituitary gland	0.001	0.998	0.000
D44.2 Parathyroid gland	0.001	0.998	0.000
D44.1 Adrenal gland	0.001	0.998	0.000
D44.0 Thyroid gland	0.001	0.998	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.001	0.998	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.001	0.998	0.000
D48.7 Other specified sites	0.001	0.998	0.000
D48.6 Breast	0.001	0.998	0.000
D48.5 Skin	0.001	0.998	0.000
D48.4 Peritoneum	0.001	0.998	0.000
D48.3 Retroperitoneum	0.001	0.998	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.001	0.998	0.000
D48.1 Connective and other soft tissue	0.001	0.998	0.000
D48.0 Bone and articular cartilage	0.001	0.998	0.000
C77.1 Intrathoracic lymph nodes	0.001	0.999	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.001	0.999	0.000
C81.9 Hodgkin's disease, unspecified	0.001	0.999	0.000
C81.7 Other Hodgkin's disease	0.001	0.999	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.001	0.999	0.000
C81.3 Lymphocytic depletion	0.001	0.999	0.000
C81.2 Mixed cellularity	0.001	0.999	0.000
C81.1 Nodular sclerosis	0.001	0.999	0.000
C81.0 Lymphocytic predominance	0.001	0.999	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.001	0.999	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.001	0.999	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.001	0.999	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.001	0.999	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.999	0.000
C84.4 Peripheral T-cell lymphoma	0.001	0.999	0.000
C84.3 Lymphoepithelioid lymphoma	0.001	0.999	0.000
C84.2 T-zone lymphoma	0.001	0.999	0.000
C84.1 Sezary's diease	0.001	0.999	0.000
C84.0 Mycosis fungoides	0.001	0.999	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.999	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.999	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.999	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.999	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.999	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.999	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.999	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.999	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.999	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.999	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.999	0.000
C88.2 Gamma heavy chain disease	0.001	0.999	0.000
C88.1 Alpha heavy chain disease	0.001	0.999	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.001	0.999	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.999	0.000
C93.7 Other monocytic leukaemia	0.001	0.999	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.999	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.999	0.000
C93.1 Chronic monocytic leukaemia	0.001	0.999	0.000
C93.0 Acute monocytic leukaemia	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
C95.9 Leukaemia, unspecified	0.001	0.999	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.999	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.999	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.999	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.999	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
C96.8 Histiocytic sarcoma	0.001	0.999	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.999	0.000
C96.3 True histiocytic lymphoma	0.001	0.999	0.000
C96.2 Malignant mast cell tumour	0.001	0.999	0.000
C96.1 Malignant histiocytosis	0.001	0.999	0.000
C96.0 Letterer-Siwe disease	0.001	0.999	0.000
H66 Suppurative and unspecified otitis media	0.001	0.999	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.001	0.999	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.999	0.000
C82.6 Cutaneous follicle centre lymphoma	0.001	0.999	0.000
C82.5 Diffuse follicle centre lymphoma	0.001	0.999	0.000
C82.4 Follicular lymphoma grade IIIb	0.001	0.999	0.000
C82.3 Follicular lymphoma grade IIIa	0.001	0.999	0.000
C82.2 Large cell, follicular	0.001	0.999	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.001	0.999	0.000
C82.0 Small cleaved cell, follicular	0.001	0.999	0.000
Z43.2 Attention to ileostomy	0.000	0.999	0.001
S42.4 Fracture of lower end of humerus	0.001	0.999	0.000
Y83.9 Surgical procedure, unspecified	0.000	0.999	0.001
C56 Malignant neoplasm of ovary	0.001	0.999	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.001	0.999	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.001	0.999	0.000
C51-C58 Malignant neoplasms of female genital organs	0.001	0.999	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.001	0.999	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.001	0.999	0.000
W00-W19 Falls	0.001	0.999	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.001	0.999	0.000
D04 Carcinoma in situ of skin	0.001	0.999	0.000
D00-D09 In situ neoplasms	0.001	0.999	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.001	0.999	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.001	0.999	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.001	0.999	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.001	0.999	0.000
K63.5 Polyp of colon	0.001	0.999	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.001	0.999	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.999	0.001
D04.6 Skin of upper limb, including shoulder	0.001	0.999	0.000
G47.8 Other sleep disorders	0.000	0.999	0.001
G47.4 Narcolepsy and cataplexy	0.000	0.999	0.001
G47.2 Disorders of the sleep-wake schedule	0.000	0.999	0.001
G47.1 Disorders of excessive somnolence [hypersomnias]	0.000	0.999	0.001
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.000	0.999	0.001
K81.1 Chronic cholecystitis	0.000	0.999	0.001
Y57.9 Drug or medicament, unspecified	0.001	0.999	0.000
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.000	0.999	0.001
M54.59 Low back pain (Site unspecified)	0.001	0.999	0.000
S43.7 Sprain and strain of other and unspecified parts of shoulder girdle	0.001	0.999	0.000
S43.6 Sprain and strain of sternoclavicular joint	0.001	0.999	0.000
S43.5 Sprain and strain of acromioclavicular joint	0.001	0.999	0.000
S43.4 Sprain and strain of shoulder joint	0.001	0.999	0.000
S43.3 Dislocation of other and unspecified parts of shoulder girdle	0.001	0.999	0.000
S43.2 Dislocation of sternoclavicular joint	0.001	0.999	0.000
S43.1 Dislocation of acromioclavicular joint	0.001	0.999	0.000
C45 Mesothelioma	0.001	0.999	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.001	0.999	0.000
D04.7 Skin of lower limb, including hip	0.001	0.999	0.000
H66.4 Suppurative otitis media, unspecified	0.001	0.999	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.001	0.999	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.001	0.999	0.000
H66.0 Acute suppurative otitis media	0.001	0.999	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.001	0.999	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.001	0.999	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.001	0.999	0.000
C46 Kaposi's sarcoma	0.001	0.999	0.000
D17 Benign lipomatous neoplasm	0.000	0.999	0.001
C83.3 Large cell (diffuse)	0.001	0.999	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.001	0.999	0.000
C13 Malignant neoplasm of hypopharynx	0.001	0.999	0.000
C11 Malignant neoplasm of nasopharynx	0.001	0.999	0.000
C10 Malignant neoplasm of oropharynx	0.001	0.999	0.000
C09 Malignant neoplasm of tonsil	0.001	0.999	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.001	0.999	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.001	0.999	0.000
C05 Malignant neoplasm of palate	0.001	0.999	0.000
C04 Malignant neoplasm of floor of mouth	0.001	0.999	0.000
C03 Malignant neoplasm of gum	0.001	0.999	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.001	0.999	0.000
C00 Malignant neoplasm of lip	0.001	0.999	0.000
C12 Malignant neoplasm of pyriform sinus	0.001	0.999	0.000
C07 Malignant neoplasm of parotid gland	0.001	0.999	0.000
C01 Malignant neoplasm of base of tongue	0.001	0.999	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.001	0.999	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.001	0.999	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.001	0.999	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.001	0.999	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.000	0.999	0.001
S42 Fracture of shoulder and upper arm	0.001	0.999	0.000
S42.41 Fracture of lower end of humerus (open)	0.001	0.999	0.000
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.999	0.001
C57 Malignant neoplasm of other and unspecified female genital organs	0.001	0.999	0.000
C53 Malignant neoplasm of cervix uteri	0.001	0.999	0.000
C51 Malignant neoplasm of vulva	0.001	0.999	0.000
C58 Malignant neoplasm of placenta	0.001	0.999	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.001	0.999	0.000
C52 Malignant neoplasm of vagina	0.001	0.999	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.001	0.999	0.000
C71 Malignant neoplasm of brain	0.001	0.999	0.000
C70 Malignant neoplasm of meninges	0.001	0.999	0.000
C69 Malignant neoplasm of eye and adnexa	0.001	0.999	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.001	0.999	0.000
D09 Carcinoma in situ of other and unspecified sites	0.001	0.999	0.000
D03 Melanoma in situ	0.001	0.999	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.001	0.999	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.001	0.999	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations